Purdue University Cancer Research (IMAGE)

Purdue University

Purdue University Cancer Research

Caption

A $399,933 SBIR Phase I grant from the National Cancer Institute to KinaRx, a Purdue University-affiliated startup, will help to advance a novel platform aimed at producing more effective drugs to treat lung and thyroid cancers. The platform targets gene mutations that help cancers grow and expand within the body. Herman O. Sintim founded KinaRx and serves as its chief scientific officer.

Credit

Herman Sintim/Purdue University

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.